Navigation Links
Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
Date:10/10/2011

BLUE BELL, Pa., Oct. 10, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of synthetic vaccines against cancers and infectious diseases, announced today that it has entered into a product development collaboration agreement with its affiliate, VGX International Inc. (KSE:011000), to co-develop  Inovio's SynCon® therapeutic vaccines for hepatitis B and C infections.

Under the terms of the agreement, VGX International will receive marketing rights for these vaccines in Asia, excluding Japan, and in return will fully fund IND-enabling and initial phase I and II clinical studies. Inovio will receive payments based on the achievement of clinical milestones and royalties based on sales in the licensed territories and retains all commercial rights in all other territories.

The first product to enter clinical testing will be a synthetic multi-antigen hepatitis C virus (HCV) vaccine covering genotypes 1a and 1b and targeting the antigens NS3/4A, which includes HCV nonstructural proteins 3 (NS3) and 4A (NS4A), as well as NS4B and NS5A proteins. The vaccine will be delivered with Inovio's CELLECTRA® delivery device. IND-enabling toxicology tests will be conducted in 1H 2012, with the intent being to initiate a phase I clinical study in late 2012. The target population for the vaccine clinical trials will be HCV infected individuals.

Supporting this product development advancement are positive preclinical results from Inovio's novel SynCon® vaccine targeting NS3/4A, which were published in the journal Molecular Therapy in the paper, "Hepatitis C Virus NS3/NS4A DNA Vaccine Induces Multi-epitope T Cell Responses in Rhesus Macaques Mimicking Human Immune Responses." Following immunization, rhesus macaques mounted strong HCV-specific T cell immune responses strikingly similar to those reported in patien
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Leadership for Life Sciences Recognized in the Philadelphia Region
2. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
3. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
4. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
5. Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
6. Inovio Pharmaceuticals to Present at Investor Conferences
7. Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results
8. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
9. Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board
10. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
11. Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
(Date:8/29/2014)... 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop ... New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists will ... that hyperspectral imaging can bring to examination procedures. ... Director of Product Development at ChemImage, will host ...
(Date:8/29/2014)... 2014  In part four of a ... pharmacy as a strategic asset, Mary Baxter, MBA, ... Cardinal Health,s Innovation Delivery Solutions business, discusses how expanding ... hospitals and patients. "Every hospital pharmacist knows ... their job in a value-based healthcare world," Baxter says. ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
... ROCKVILLE, Md., Oct. 24, 2011 Vanda Pharmaceuticals Inc. ... has named Bob Repella as Senior Vice President, Chief ... has more than 25 years of experience in the ... sales, new product development and commercial operations.   ...
... 24, 2011 Pinnacle Biologics, Inc., a privately held ... an Orphan Drug Designation (ODD) for their product PHOTOFRIN® ... in the treatment of Malignant Pleural Mesothelioma. ... the lining of the lungs. It is a rare, ...
Cached Medicine Technology:Vanda Pharmaceuticals Appoints Chief Commercial Officer 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 3Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 4
(Date:8/29/2014)... (HealthDay News) -- The West African Ebola outbreak took a ... an estimated 500 new cases this week -- the biggest ... cases arose in Liberia, the U.N. health agency said, but ... Associated Press reported. "There are serious problems ... the WHO report. "The situation is worsening in Liberia and ...
(Date:8/29/2014)... September yoga month was created by the Yoga Health ... benefits. To support this Ekhart Yoga is offering those ... , This 4 week guided online yoga program is ... yoga regularly from their own home. Led by Esther ... for all levels, and the dynamic classes will help ...
(Date:8/29/2014)... RBS Reputation Management has brought a new ... service is to help those individuals and organizations that are ... Book. The service would push down the ranking of Scam ... fully invisible on Google. , RBS Reputation Management provides ... asked how company can provide guarantee of results with the ...
(Date:8/29/2014)... Last week, the Fed reported an increase ... production rose to 0.4% while manufacturing output progressed to 1.0%. ... largest boost since February this year. Capacity use has increased ... well – an increase that could be attributed to the ... rate, which is a measure of slack across the industries. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Ethane Web ... recently launched a new service named HTML web design. ... based service. Before tailoring the service, Ethane Web Technologies ... other companies. The company has done its best efforts ... and able to deliver outstanding results to clients. ...
Breaking Medicine News(10 mins):Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Ethane Web Technologies Launches a New Web Design Service 2
... that the usage of aspirin to prevent heart problem have ... of Pittsburgh Graduate School of Public Health (GSPH) and others ... Medicine. It said that African Americans and diabetics do not ... medical centers of US and Europe measured regular use of ...
... conducted by Jerald Greenberg professor of management and human resources ... that pay cuts resulted in loss of money and sleep ... in different cities in the Northeast. ,In these ... salary by 10%. The author conducted a supervisor training in ...
... Derek Griffiths, Ph.D., professor of geriatric medicine, University of Pittsburgh ... to the reduced activity of the orbitofrontal cortex of the ... recent issue of the Journal of Urology. He studied the ... , He analyzed the brain activity of 6 normal people ...
... was stated that Malaria affects 300 to 500 million people ... leading// cause of illness and death in the sub-Saharan African ... the Uganda Malaria Surveillance Project and Julia Critchley of the ... drugs showed better efficiency when used in the treatment of ...
... the number of breast cancer cases in the UK. As ... with the ductal carcinoma// in situ (DCIS) during 2002. The ... the hormone therapy drugs are capable of preventing the recurrence ... anastrozole are being studied. The DCIS is considered a pre-cancerous ...
... with regard to a ten-year-old plan to scale down the ... and the rich with regard to this however remains unchanged. ... the establishment of 34 networks for providing better treatment. As ... ,Improvements have been made with regard to ...
Cached Medicine News:Health News:Pay Cut Leads To Increased Levels Of Insomnia Among Workers 2Health News:Older Malarial Drugs Vs New Ones 2
Suction catheter with thumb valve, two eyes, whistle tip...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
... 200 Corneal Topographer is the result of ... leader in product innovation and value, continues ... diagnostic instrumentation. The CT 200 is faster ... and repeatable results. The CT 200 is ...
... The patented, accurate and proven DGH-KOI ... the patented MOD III or Neumann ... perfect RK/AK knife. Once a fine ... time-tested quality are then blended to ...
Medicine Products: